December 12, 2024 05:28 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | INDIA bloc to knock on Supreme Court's doors over alleged EVM manipulation during Maharashtra polls | 'Babri Masjid should be rebuilt in Bengal's Murshidabad': TMC MLA Humayun Kabir sparks row | Rajnath Singh calls on Russian Prez Vladimir Putin in Moscow, discusses bilateral defence cooperation | Police to investigate conspiracy angle in Mumbai bus accident that killed 7 | Mamata Banerjee should lead INDIA bloc: Lalu Prasad Yadav | Opposition moves no-confidence motion against VP Jagdeep Dhankar in RS

Diabetes-inducing blood vessel damage could be prevented by a growth factor, study finds

Jan 06, 2019, at 09:11 pm

London, Jan 6 (IBNS): Scientists have identified a growth factor found in the kidneys that could minimise the diabetes-inducing effects of blood vessel damage.

Four clinical trials suggest doctors focus on heart disease, not just glucose, says study

Jul 09, 2017, at 01:03 am

New York, July 8 (IBNS): Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type 2 diabetes management can leave patients at risk for heart attack and stroke. But results from four recent randomized clinical trials suggest that using medications that offer glucose control while reducing the risk for cardiovascular disease could improve patient outcomes.

Research elucidates hormone ghrelin’s role in blood glucose regulation, a finding with promising implications for diabetes treatment

May 10, 2017, at 03:38 am

Dallas, May 9 (IBNS): UT Southwestern research investigating the blood glucose-regulatory actions of the hormone ghrelin may have implications for development of new treatments for diabetes.